公司概覽
業務類別 --
業務概覽 BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
公司地址 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
電話號碼 +81 333500111
傳真號碼 +81 333501180
公司網頁 http://www.bml.co.jp
員工數量 8013
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Kenji Shibata Director, Executive Officer and General Manager, BML Clinical Testing Headquarters and General Laboratory Fourth Clinical Testing Department -- 24/06/2025
Mr. Yuji Yamashita Director, Executive Officer and General Manager, System Division -- 24/06/2025
Mr. Kensuke Kondo Director and President -- 24/06/2025
Mr. Nobuki Arai Director, Vice President and General Manager, Overseas Business Office -- 24/06/2025
Mr. Norihisa Takebe Director, Senior Managing Executive Officer and General Manager, Planning Division -- 24/06/2025
Mr. Hideaki Osawa Director, Executive Officer and General Manager, Sales Division, Solution Proposal Department and Medical Research Business Division -- 24/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Shigeru Osawa Independent Director 24/06/2025
Mr. Kenji Shibata Director, Executive Officer and General Manager, BML Clinical Testing Headquarters and General Laboratory Fourth Clinical Testing Department 24/06/2025
Mr. Yuji Yamashita Director, Executive Officer and General Manager, System Division 24/06/2025
Mr. Kensuke Kondo Director and President 24/06/2025
Mr. Nobuki Arai Director, Vice President and General Manager, Overseas Business Office 24/06/2025
Mr. Norihisa Takebe Director, Senior Managing Executive Officer and General Manager, Planning Division 24/06/2025
Mr. Hideaki Osawa Director, Executive Officer and General Manager, Sales Division, Solution Proposal Department and Medical Research Business Division 24/06/2025
Ms. Yukiko Yoritaka Independent Director 24/06/2025
Mr. Tatsuharu Arai Independent Director 24/06/2025
 
所屬ETF (更新日期: 07/03/2026 04:30)
代號 名稱 佔比% 持有日期
IEFAiShares Core MSCI EAFE ETF0.35%28/02/2026
AVDVAvantis International Small Cap Val ETF0.30%28/02/2026
SCZiShares MSCI EAFE Small-Cap ETF0.19%28/02/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.16%28/02/2026
FNDCSchwab Fundamental International SmEqETF0.15%28/02/2026
SCHCSchwab International Small-Cap Eq ETF™0.12%28/02/2026
AVDEAvantis International Equity ETF0.08%28/02/2026
IDEViShares Core MSCI Intl Dev Mkts ETF0.08%28/02/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.05%27/02/2026
VTVanguard Total World Stock ETF0.04%31/01/2026
IPACiShares Core MSCI Pacific ETF0.01%28/02/2026
ISCFiShares MSCI Intl Small-Cap Mltfct ETF0.01%28/02/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.01%24/02/2026
SCJiShares MSCI Japan Small-Cap ETF0.01%28/02/2026
AVDSAvantis International Small Cp Eq ETF0.01%28/02/2026
AVSDAvantis Responsible International Eq ETF0.001%28/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%27/02/2026
ISVLiShares Intl Dev Sm Cp Val Fctr ETF<0.000001%28/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.